Hormônios femininos e hemostasia Female hormones and hemostasis
Os hormônios femininos exógenos utilizados para contracepção ou para terapia hormonal (TH) no climatério estão associados a aumento de risco para tromboembolismo venoso (TEV), principalmente por provocarem alterações pró-coagulantes na hemostasia. Este risco não é cumulativo e parece ser maior no primeiro ano de uso.
Carolina Sales Vieira +2 more
openaire +1 more source
Intelligent mobile health management for the risk of gastrointestinal bleeding in anticoagulated patients with cardiovascular disease. [PDF]
Li T +6 more
europepmc +1 more source
AI-generated peptides for research and clinical practice. [PDF]
Frontroth JP.
europepmc +1 more source
Comment on "Postpartum well-being in hemophilia carriers and women with von Willebrand disease". [PDF]
Majluf-Cruz A.
europepmc +1 more source
Special Issue "miRNAs in the Era of Personalized Medicine: From Biomarkers to Therapeutics 2.0". [PDF]
Mc Cormack BA +6 more
europepmc +1 more source
Debate: Does the distal radial approach offer added value over the conventional radial approach? Yes, it does. [PDF]
Arroyo Úcar E.
europepmc +1 more source
HEMOSTASIA E PROCEDIMENTOS ANTI-HEMORRÁGICOS
Tales do Prado +3 more
openaire +1 more source
Purse-string suture and 3-way stopcock for effective venous hemostasis in structural heart procedures: the SUTURE-3 study. [PDF]
Camacho Freire SJ +13 more
europepmc +1 more source

